Social Media Influencers Driving Unofficial Trade for Unlicensed Weight-Loss Medication

An underground economy for unapproved weight-loss drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.

Experimental Drug Gaining Traction Via Social Media

The experimental drug, which remains in research studies, is being promoted by social media influencers for its alleged weight-reducing effects. Viewers are encouraged to message these profiles directly for source information, while also obtaining promotional offers.

Active Trade on Messaging Platforms

Separately, a robust trade exists on messaging services, where groups with thousands of members share comparison photos, injection guides and claims of rapid UK delivery. Vendors promote the drug there before directing customers to WhatsApp for transactions.

Understanding The Experimental Drug

Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.

Healthcare Professionals Express Concerns

However, doctors and pharmacists have warned that the sale of what remains an unlicensed drug in the UK is a cause for concern and could lead to users injecting substances of uncertain source.

Some professionals stated the demand for retatrutide could be connected to the increasing price of licensed slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Selling the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that must not be marketed or supplied for personal consumption under the British medical regulations.

Several influencers attempt to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still breach medicines, marketing, and consumer regulations, potentially leading to fines, prosecution or prison.

Platform Reaction and Content Elimination

According to the social media company, the platform has removed problematic content and banned associated keywords and search suggestions. The organization said it was committed to keeping the service safe and allocating resources in strengthening enforcement strategies.

Digital Trading Activities

Research also discovered groups with up to 9,000 members marketing retatrutide using Telegram's integrated search feature, which operates like a public directory. Entering “retatrutide” instantly brings up groups with numerous of users, filled with images of slimming results, glowing reviews and step-by-step instructions for preparing or administering at home.

Within moments of joining one group, a seller posted WhatsApp details, where most purchases take place. The vendor sent an instruction manual and guaranteed shipping within 48 hours. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one asked about body mass, health issues or previous experience.

Product Details and Pricing

Within these groups, posts display black plastic parcels with Royal Mail labels, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at residence with sterile water, or pre-filled pens usually sold at 160 pounds for 20 milligrams. When asked how much time a injector should last, sellers give conflicting responses varying between a several days to “depends on your body”.

Platform Moderation and Safety Measures

A spokesperson for Telegram said it actively monitored harmful material on its service including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are administering materials they cannot confirm. Although the research behind retatrutide is valid, these digital products may not contain what they claim,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to recent price rises for approved weight-loss medications such as Mounjaro. “With costs rising, patients are using social media. But fake treatments are highly risky. You cannot know what’s inside or whether the environment they were made in was clean,” she said.

Her team has previously seen individuals harmed by self-injection from unverified suppliers. “We understand the disappointment, but buying from messaging apps or WhatsApp is gambling with your well-being,” said Wyllie. “These materials could be impure or improperly measured.”

Producer Position

A representative from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a company investigational product not yet authorized … may subject patients to potentially significant medical dangers”.